To see a current example of local bureaucracy run amok, one need look no further than Somerville, where city officials are giving the run-around to a promising proposal, and giving up their power to a big, corporate developer.
A Cambridge developer is testing the Porter Square area as a new growth node for life science development with a proposal for a 42,000-square-foot lab project.
The first life science development in Somerville’s Brickbottom neighborhood has secured an initial tenant in a California biopharma company.
A Boston developer is proposing lab space in the Inner Belt as life science growth spills into new sections of East Somerville.
A new ownership group is making big changes to plans for a commercial development on the outskirts of Somerville’s Union Square, dropping a 330-room hotel while retaining a pair of office-lab towers.
For its next development block at Somerville’s Assembly Row, Federal Realty Investment Trust is seeking approval for a 381,529-square-foot life science building.
Developers of the first major life science building in Somerville’s Boynton Yards have recapitalized the property in a $478-million deal with a San Francisco investor joining the ownership.
BioMed Realty has completed its $163 million acquisition of a development site in Somerville’s expanding Assembly Square commercial cluster, with plans for 1.3 million square feet of office, lab and retail space.
